CUMBERLAND PHARMACEUTICALS INC — All Filings
1,003 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
10-Q/A
3
3/A
4
4/A
424B4
424B5
5
8-A12B
8-A12B/A
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
DEF 14A
DEFA14A
DEFR14A
DEL AM
EFFECT
REGDEX
S-1
S-1/A
S-3
S-3/A
S-8
SC 13G
SC 13G/A
SC TO-I
SC TO-I/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0001628280-25-037923 | Aug 5, 2025 | — |
| UPLOAD | — | 0000000000-25-008156 | Aug 4, 2025 | — |
| 4 | FORM 4 | 0001628280-25-034816 | Jul 11, 2025 | Jun 2, 2025 |
| 4 | FORM 4 | 0001628280-25-034820 | Jul 11, 2025 | Jun 2, 2025 |
| 4 | FORM 4 | 0001628280-25-034814 | Jul 11, 2025 | Jun 2, 2025 |
| 4 | FORM 4 | 0001628280-25-034818 | Jul 11, 2025 | Jun 2, 2025 |
| 4 | FORM 4 | 0001628280-25-029854 | Jun 6, 2025 | May 1, 2025 |
| 4 | FORM 4 | 0001628280-25-029849 | Jun 6, 2025 | May 1, 2025 |
| 4 | FORM 4 | 0001628280-25-029856 | Jun 6, 2025 | May 1, 2025 |
| 4 | FORM 4 | 0001628280-25-029852 | Jun 6, 2025 | May 1, 2025 |
| SCHEDULE 13G | — | 0000950170-25-072872 | May 15, 2025 | — |
| 4 | FORM 4 | 0001628280-25-024355 | May 9, 2025 | Apr 1, 2025 |
| 4 | FORM 4 | 0001628280-25-024353 | May 9, 2025 | Apr 1, 2025 |
| 4 | FORM 4 | 0001628280-25-024346 | May 9, 2025 | Apr 1, 2025 |
| 4 | FORM 4 | 0001628280-25-024349 | May 9, 2025 | Apr 1, 2025 |
| 10-Q | 10-Q | 0001628280-25-024342 | May 9, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0001628280-25-022753 | May 6, 2025 | — |
| 8-K | 8-K | 0001628280-25-020222 | Apr 28, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-038616 | Apr 24, 2025 | — |
| 4 | FORM 4 | 0001628280-25-016745 | Apr 4, 2025 | Mar 3, 2025 |
| 4 | FORM 4 | 0001628280-25-016743 | Apr 4, 2025 | Mar 3, 2025 |
| 4 | FORM 4 | 0001628280-25-016741 | Apr 4, 2025 | Mar 3, 2025 |
| 4 | FORM 4 | 0001628280-25-016742 | Apr 4, 2025 | Mar 3, 2025 |
| 8-K | 8-K | 0001628280-25-013875 | Mar 19, 2025 | — |
| ARS | ARS | 0001628280-25-013572 | Mar 18, 2025 | — |
| 4 | FORM 4 | 0001628280-25-013527 | Mar 18, 2025 | Mar 17, 2025 |
| 4 | FORM 4 | 0001628280-25-013522 | Mar 18, 2025 | Mar 17, 2025 |
| 4 | FORM 4 | 0001628280-25-013538 | Mar 18, 2025 | Mar 17, 2025 |
| 4 | FORM 4 | 0001628280-25-013531 | Mar 18, 2025 | Mar 17, 2025 |
| 4 | FORM 4 | 0001628280-25-013534 | Mar 18, 2025 | Mar 17, 2025 |
| 4 | FORM 4 | 0001628280-25-013541 | Mar 18, 2025 | Mar 17, 2025 |
| 4 | FORM 4 | 0001628280-25-013544 | Mar 18, 2025 | Mar 17, 2025 |
| 4 | FORM 4 | 0001628280-25-013546 | Mar 18, 2025 | Mar 17, 2025 |
| 4 | FORM 4 | 0001628280-25-013548 | Mar 18, 2025 | Mar 17, 2025 |
| 4 | FORM 4 | 0001628280-25-013513 | Mar 18, 2025 | Mar 16, 2025 |
| DEF 14A | DEF 14A | 0001628280-25-011735 | Mar 10, 2025 | Dec 31, 2024 |
| DEFA14A | DEFA14A | 0001628280-25-011736 | Mar 10, 2025 | — |
| 10-K | 10-K | 0001628280-25-011366 | Mar 7, 2025 | Dec 31, 2024 |
| 8-K | 8-K | 0001628280-25-009967 | Mar 4, 2025 | — |
| 8-K | 8-K | 0001628280-25-006430 | Feb 19, 2025 | — |
| 8-K | 8-K | 0001628280-25-005744 | Feb 14, 2025 | — |
| 424B5 | 424B5 | 0001628280-25-005760 | Feb 14, 2025 | — |
| SCHEDULE 13G | — | 0001628280-25-005480 | Feb 13, 2025 | — |
| SCHEDULE 13G | — | 0001104659-25-011461 | Feb 11, 2025 | — |
| 8-K | 8-K | 0001628280-25-003753 | Feb 4, 2025 | — |
| 4/A | FORM 4/A | 0001628280-25-003183 | Jan 30, 2025 | Mar 25, 2024 |
| 4/A | FORM 4/A | 0001628280-25-003184 | Jan 30, 2025 | Mar 25, 2024 |
| 4/A | FORM 4/A | 0001628280-25-003185 | Jan 30, 2025 | Mar 25, 2024 |
| 4/A | FORM 4/A | 0001628280-25-003186 | Jan 30, 2025 | Mar 25, 2024 |
| 4/A | FORM 4/A | 0001628280-25-003181 | Jan 30, 2025 | Mar 25, 2024 |